Genesys Capital
Genesys Capital
Type of Funding
Venture Capital
Max Funding
N/A
Region
Federal/National
Application Difficuty
Fairly simple
Processing Time
Slow (A few months)
Province
All Of Canada
Industry
Health and other services.
Funding Goals
Start-up Funding.
Demographic
N/A
Incorporated
No
Contact
(416) 598-4900
Apply For A Loan
Business location – Canada
Monthly Revenue – $10K +
Time in Business – 6 months +
Funds in 24 hours
$10,000 to $800,000
Details
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology.
Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising biotechnology investment opportunities.
Genesys is one of the largest Canadian-based venture capital firms exclusively focused on the life sciences industry.
Eligibility
Early to mid-stage Canadian life sciences companies which are translating world-class science into marketable products and services that target large and growing markets.
Similar funding programs
Venture Capital
Ferst Capital Partners is an investment firm on the forefront of change.
They strategic capital and support to startups. They provide a home for Canada's next generation of exceptional company builders.
Max Funding N/A
Ferst Capital Partners
Venture Capital
Leveraging the connections with public and private funding organizations, Communitech funding concierge provides varying levels of detail, depending on your needs. From a high-level overview of programs and accessibility criteria to a deep dive into whats right for you, we help you navigate the wild world of funding.
Max Funding N/A
Communitech
Venture Capital
YUL has been created in 2013 to institutionalize active angel investing, introducing a sizable, consistent, entrepreneur-friendly & decisive investment partner to the Montreal technology ecosystem
They invest in dynamic teams of entrepreneurs that have deep expertise in sizable markets theyre trying to disrupt, as well as shippable products having demonstrated an initial market traction and user acceptance.
Max Funding N/A
YUL Ventures